Nature's Sunshine Products Reports Receipt of Noncompliance Notice from Nasdaq

Nature's Sunshine Products Inc. ("the Company")
(NASDAQ:NATRE) announced today that, on November 16, 2005, it received
notice from The Nasdaq Stock Market that, due to the Company's delayed
filing of its Quarterly Report on Form 10-Q for the quarter ended
September 30, 2005, the Company was no longer in compliance with
Marketplace Rule 4310(c)(14). As a result, the Company's common stock
is subject to possible delisting from The Nasdaq Stock Market at the
opening of business on November 28, 2005. In accordance with the
procedures of The Nasdaq Stock Market, the Company will request a
hearing before the Nasdaq Listing Qualifications Panel to appeal its
possible delisting. The Company's appeal to the Panel will
automatically stay the delisting of its common stock pending the
Panel's review and determination. There can be no assurance that the
Panel will grant the Company's request for continued listing, and,
until a determination is made, the symbol "E" will be added to the
Company's trading symbol.
   The Company previously reported that it is currently reviewing
selected financial information with respect to certain of its foreign
operations and, therefore, the Company's independent auditor has not
completed its review of the Company's financial statements for the
three and nine months periods ended September 30, 2005. The Company
plans to file tomorrow its Quarterly Report on Form 10-Q for the
quarter ended September 30, 2005, which will include unaudited
consolidated financial statements for the three and nine month periods
ended September 30, 2005 that have not been reviewed by the Company's
independent auditor. The Company believes that the unaudited
consolidated financial statements contained in the 10-Q to be filed
tomorrow are a fair presentation of the Company's financial position
as of September 30, 2005. Upon the completion of the Company's review
and the review by the Company's independent auditor of the selected
financial information with respect to certain of its foreign
operations, the Company intends to file an amendment to the 10-Q to
reflect the review of the Company's independent auditor and will
reflect material changes, if any, resulting from such reviews.

   About Nature's Sunshine

   Nature's Sunshine Products manufactures and markets through direct
sales encapsulated and tableted herbal products, high quality natural
vitamins, and other complementary products. In addition to the United
States, the Company has operations in Japan, Mexico, Central America,
South Korea, Canada, Dominican Republic, Venezuela, Ecuador, Peru, the
United Kingdom and Ireland, Colombia, Brazil, Thailand, Israel,
Singapore and Taiwan. The Company also has exclusive distribution
agreements with selected companies in Argentina, Australia, Chile, New
Zealand, Norway, and the Russian Federation.

   Statements in this press release concerning the Company's business
outlook or future economic performance, anticipated profitability,
revenues, expenses or other financial items, and product line growth,
together with other statements that are not historical facts, are
"forward-looking statements" as that term is defined under Federal
Securities Laws. "Forward-looking statements" are subject to risks,
uncertainties and other factors, which could cause actual results to
differ materially from those set forth in such statements. Such risks,
uncertainties, and factors include, but are not limited to, foreign
business risks, industry cyclicality, fluctuations in customer demand
and order pattern, changes in pricing and general economic conditions,
as well as other risks detailed in the Company's filings with the
Securities and Exchange Commission. The Company disclaims any
obligations to update any forward-looking statement as a result of
developments occurring after the date of this press release.